Neurological toxicity due to antimonial treatment for refractory visceral leishmaniasis

INTRODUCTION: Although pentavalent antimonials are no longer considered the first-line therapy for visceral leishmaniasis in the developed world, they are still used in certain geographical areas and in refractory cases. These drugs have a great number of adverse effects; however, neurological toxic...

Descripción completa

Detalles Bibliográficos
Autores principales: Maristany Bosch, Marta, Cuervo, Guillermo, Matas Martín, Elisabeth, Veciana de las Heras, Misericordia, Pedro Pérez, Jordi, Martínez Yélamos, Sergio, Sabé Fernández, Nuria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790161/
https://www.ncbi.nlm.nih.gov/pubmed/35112035
http://dx.doi.org/10.1016/j.cnp.2021.03.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790161/
https://www.ncbi.nlm.nih.gov/pubmed/35112035
http://dx.doi.org/10.1016/j.cnp.2021.03.008

Ejemplares similares